Molecular Medicine Today logo Elsevier logo

Publisher: Elsevier

Volume 5, Number 2, 1 February 1999
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Targeting protein breakdown to treat cancer
pp. 48-49(2)
Author: Bonn D.

Virus buster for transfusion blood
pp. 49-50(2)
Author: Dorrell S.

Turning off RB for a healthy heart?
pp. 50-51(2)
Author: Fricker J.

New light on retinal gene therapy
pp. 52-52(1)
Author: Aldred M.A.

Tolerating adenoviral vectors
pp. 53-53(1)
Author: Caplan N.J.

Alcoholic mice shed light on the human condition
pp. 53-53(1)
Author: Evans K.L.

The importance of location
pp. 54-54(1)
Author: Lindsay J.

Is extravasation a Fas-regulated process?
pp. 61-67(7)
Authors: Walsh K.; Sata M.

Urinary analyte screening: a noninvasive detection method for Down syndrome?
pp. 68-73(6)
Authors: Canick J.A.; Kellner L.H.; Cole L.A.; Cuckle H.S.

New perspectives on the etiology of systemic sclerosis
pp. 74-78(5)
Authors: Artlett C.M.; Smith J.B.; Jimenez S.A.

Xeroderma pigmentosum and the role of UV-induced DNA damage in skin cancer
pp. 86-94(9)
Authors: van Steeg H.; Kraemer K.H.

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A